WO2026109936 - D-BHB (D-BETA-HYDROXYBUTYRATE) FOR USE IN THE TREATMENT OF MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY (MADD)
National phase entry is expected:
Publication Number
WO/2026/109936
Publication Date
28.05.2026
International Application No.
PCT/IB2025/000603
International Filing Date
21.11.2025
Title **
[English]
D-BHB (D-BETA-HYDROXYBUTYRATE) FOR USE IN THE TREATMENT OF MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY (MADD)
[French]
D-BHB (D-BÊTA-HYDROXYBUTYRATE) DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU DÉFICIT MULTIPLE EN ACYL-COA DÉSHYDROGÉNASES (DMAD)
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Inventors
LASSUEUR, Steve
RICHARD, Joy
DELERIVE, Philippe
Priority Data
63/724,177
22.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3657 | |
| EPO | Filing, Examination, Granting | 14475 | |
| Japan | Filing, Examination, Granting | 2154 | |
| South Korea | Filing, Examination, Granting | 2066 | |
| USA | Filing, Examination, Granting | 6690 |
Total:
29,042
Contact Us
Abstract[English]
The present invention relates to the use of D-beta-hydroxybutyrate (D-BHB) in the treatment or dietary management of multiple acyl-CoA dehydrogenase deficiency (MADD), for example, in the prevention and/or amelioration of one or more symptoms associated with MADD. Further provided herein are methods of treatment or dietary managements of MADD in a subject in need, comprising administering to said subject a composition comprising D-BHB as the active ingredient.[French]
La présente invention concerne l'utilisation de D-bêta-hydroxybutyrate (D-BHB) dans le traitement ou la gestion diététique du déficit multiple en acyl-CoA déshydrogénases (DMAD), par exemple, dans la prévention et/ou l'amélioration d'un ou de plusieurs symptômes associés au DMAD. L'invention concerne en outre des méthodes de traitement ou de gestions diététiques du DMAD chez un sujet dont l'état le nécessite, comprenant l'administration audit sujet d'une composition comprenant du D-BHB en tant que principe actif.